Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eldad Melamed

Showing results (41-50 of 120) with videos related to

Pageof 12
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|August 29, 2012
Trial designs used to study neuroprotective therapy in Parkinson's diseaseAnthony E Lang, Eldad Melamed, Werner Poewe, et al.
Pharmacology & Toxicology|June 28, 2003
Riluzole, an inhibitor of glutamatergic transmission, suppresses levodopa-induced rotations in 6-hydroxydopamine-lesioned ratsYossi Gilgun-Sherki, Eldad Melamed, Ilan Ziv, et al.
Journal of Neurochemistry|December 9, 2010
Wnt signaling pathway overcomes the disruption of neuronal differentiation of neural progenitor cells induced by oligomeric amyloid β-peptideAdi Shruster, Hagit Eldar-Finkelman, Eldad Melamed, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 15, 2006
Effect of deep brain subthalamic stimulation on camptocormia and postural abnormalities in idiopathic Parkinson's diseaseMark A Hellmann, Ruth Djaldetti, Zvi Israel, et al.
Journal of Molecular Neuroscience : MN|January 19, 2005
Embryonic and adult stem cells as a source for cell therapy in Parkinson's diseaseYossef S Levy, Merav Stroomza, Eldad Melamed, et al.
The Israel Medical Association Journal : IMAJ|February 3, 2006
Adult stem cells for neuronal repairRan Barzilay, Yossef S Levy, Eldad Melamed, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|June 28, 2011
Respiratory distress: an unrecognized non-motor phenomenon in patients with parkinsonismShlomit Yust-Katz, David Shitrit, Eldad Melamed, et al.
Brain Research|October 15, 2003
Riluzole suppresses experimental autoimmune encephalomyelitis: implications for the treatment of multiple sclerosisYossi Gilgun-Sherki, Hana Panet, Eldad Melamed, et al.
Pharmacology & Toxicology|August 6, 2003
The CB1 cannabinoid receptor agonist, HU-210, reduces levodopa-induced rotations in 6-hydroxydopamine-lesioned ratsYossi Gilgun-Sherki, Eldad Melamed, Raphael Mechoulam, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 31, 2007
Effect of subcutaneous apomorphine on tremor in idiopathic Parkinson's diseaseMark A Hellmann, Tilda Sabach, Eldad Melamed, et al.
Pageof 12

Showing results (41-50 of 120) with videos related to

Sort By:
Pageof 12
Movement Disorders : Official Journal of the Movement Disorder Society|August 29, 2012
Trial designs used to study neuroprotective therapy in Parkinson's diseaseAnthony E Lang, Eldad Melamed, Werner Poewe, et al.
Pharmacology & Toxicology|June 28, 2003
Riluzole, an inhibitor of glutamatergic transmission, suppresses levodopa-induced rotations in 6-hydroxydopamine-lesioned ratsYossi Gilgun-Sherki, Eldad Melamed, Ilan Ziv, et al.
Journal of Neurochemistry|December 9, 2010
Wnt signaling pathway overcomes the disruption of neuronal differentiation of neural progenitor cells induced by oligomeric amyloid β-peptideAdi Shruster, Hagit Eldar-Finkelman, Eldad Melamed, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 15, 2006
Effect of deep brain subthalamic stimulation on camptocormia and postural abnormalities in idiopathic Parkinson's diseaseMark A Hellmann, Ruth Djaldetti, Zvi Israel, et al.
Journal of Molecular Neuroscience : MN|January 19, 2005
Embryonic and adult stem cells as a source for cell therapy in Parkinson's diseaseYossef S Levy, Merav Stroomza, Eldad Melamed, et al.
The Israel Medical Association Journal : IMAJ|February 3, 2006
Adult stem cells for neuronal repairRan Barzilay, Yossef S Levy, Eldad Melamed, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|June 28, 2011
Respiratory distress: an unrecognized non-motor phenomenon in patients with parkinsonismShlomit Yust-Katz, David Shitrit, Eldad Melamed, et al.
Brain Research|October 15, 2003
Riluzole suppresses experimental autoimmune encephalomyelitis: implications for the treatment of multiple sclerosisYossi Gilgun-Sherki, Hana Panet, Eldad Melamed, et al.
Pharmacology & Toxicology|August 6, 2003
The CB1 cannabinoid receptor agonist, HU-210, reduces levodopa-induced rotations in 6-hydroxydopamine-lesioned ratsYossi Gilgun-Sherki, Eldad Melamed, Raphael Mechoulam, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 31, 2007
Effect of subcutaneous apomorphine on tremor in idiopathic Parkinson's diseaseMark A Hellmann, Tilda Sabach, Eldad Melamed, et al.
Pageof 12